Scalpel Weekly News

Week of: November 12, 2012

IN THE NEWS


All Ameridose Drug Products Recalled Due to Potential Contamination Exacerbating Critical Shortage of Life-Saving Drugs

The FDA announced that Ameridose, LLC, based in Westborough, Mass., is voluntarily recalling all of its unexpired products in circulation. Products from Ameridose can be identified by markings that indicate Ameridose by name or by its company logo disclaimer icon. Click title to continue reading...


 
MEDICAL ALERTS


Contamination Identified in Additional Medical Products from Pharmacy Linked to Ongoing Deadly Fungal Meningitis Outbreak

As of November 5, 2012, 419 cases of fungal meningitis have been reported to the CDC, including 30 deaths. These cases include 409 cases of fungal meningitis, stroke due to presumed fungal meningitis, or other central nervous system-related infection meeting the outbreak case definition, plus ten peripheral joint infections. Click title to continue reading...



Risk of Potentially Fatal Serious Bleeding Events with Anticoagulants Including Pradaxa

The FDA has evaluated new information about the risk of serious bleeding associated with use of the anticoagulants (blood thinners) dabigatran (Pradaxa) and warfarin (Coumadin, Jantoven, and generics). Following the approval of Pradaxa, the FDA received a large number of post-marketing reports of bleeding among Pradaxa users. Click title to continue reading...



FDA Expands Use of Xarelto to Treat and Reduce Recurrence of Blood Clots

The FDA expanded the approved use of Xarelto (rivaroxaban) to include treating deep vein thrombosis (DVT) or pulmonary embolism (PE), and to reduce the risk of recurrent DVT and PE following initial treatment. Click title to continue reading...


  CASE ALERTS


Failure to Order Follow-up Tests Does Not Trigger Statute of Limitations, Nor Does Cancer Diagnosis in Negligent Failure to Diagnose Cancer Case

A man underwent a colonoscopy. The doctor who performed the colonoscopy did not order a follow-up colonoscopy within two to three years. A little over three years after the colonoscopy, the man was diagnosed with colon cancer. Click title to continue reading...



Attorney-Client Privilege May Apply to Hospital’s Suicide Investigation Reports, Only If Sufficient Information About Content of Reports Disclosed

A man overdosed on pills and left a suicide note. He was admitted to the hospital where the attending physician transferred him to the in-patient psychiatric unit where suicide precautions were taken. Click title to continue reading...



Provisions of State Statute Governing Medical Injury Screening Panels Violated State Constitutional Right to Jury Trial

The plaintiff sued the defendants for medical malpractice. Pursuant to a state statute governing medical injury screening panels, the parties participated in a two-day medical injury screening panel hearing. Click title to continue reading...